Why the study?
Does rivaroxaban improve medication adherence compared to dabigatran or apixaban in adult patients using NOACs?
Population
21,175 adult patients from the Humana database with ≥2 dispensings of NOAC agents in 2014, at least 180 days…
Comparison
Rivaroxaban vs Dabigatran and apixaban
Design
Cohort
Authors
Loading...
Adherence differences among NOACs in claims data should not yet change prescribing; leaves open causal effects on persistence.
Does rivaroxaban improve medication adherence compared to dabigatran or apixaban in adult patients using NOACs?
Rivaroxaban users demonstrated significantly higher medication adherence compared to apixaban and dabigatran users based on the PQA measure in a retrospective claims database analysis.
McHorney et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: